Cadre Holdings, Inc. (NYSE:CDRE – Get Free Report) Director Nicolas Sokolow sold 5,000 shares of Cadre stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $33.25, for a total transaction of $166,250.00. Following the sale, the director now directly owns 482,620 shares in the company, valued at approximately $16,047,115. The trade was a 1.03 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Nicolas Sokolow also recently made the following trade(s):
- On Monday, November 25th, Nicolas Sokolow sold 1,095 shares of Cadre stock. The stock was sold at an average price of $34.10, for a total value of $37,339.50.
Cadre Stock Down 0.3 %
Shares of NYSE CDRE opened at $33.44 on Thursday. The company has a quick ratio of 1.96, a current ratio of 3.01 and a debt-to-equity ratio of 0.65. The business’s 50 day moving average is $36.43 and its two-hundred day moving average is $34.96. Cadre Holdings, Inc. has a 52-week low of $29.18 and a 52-week high of $40.28. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 40.28, a PEG ratio of 1.98 and a beta of 1.30.
Cadre Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, November 1st were issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date was Friday, November 1st. Cadre’s dividend payout ratio (DPR) is currently 42.17%.
Hedge Funds Weigh In On Cadre
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of Cadre by 21.2% in the first quarter. Vanguard Group Inc. now owns 1,180,212 shares of the company’s stock valued at $42,724,000 after acquiring an additional 206,564 shares in the last quarter. Advisors Asset Management Inc. purchased a new stake in Cadre during the 1st quarter worth about $358,000. Price T Rowe Associates Inc. MD raised its position in Cadre by 32.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 460,500 shares of the company’s stock valued at $16,671,000 after purchasing an additional 113,722 shares in the last quarter. California State Teachers Retirement System boosted its stake in shares of Cadre by 11.5% in the 1st quarter. California State Teachers Retirement System now owns 22,234 shares of the company’s stock valued at $805,000 after buying an additional 2,301 shares during the period. Finally, Zimmer Partners LP acquired a new position in shares of Cadre during the first quarter worth about $11,990,000. Hedge funds and other institutional investors own 43.95% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Roth Mkm lowered their price target on Cadre from $39.00 to $37.00 and set a “buy” rating for the company in a report on Thursday, November 7th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $39.75.
Read Our Latest Report on Cadre
About Cadre
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Stories
- Five stocks we like better than Cadre
- How to Plot Fibonacci Price Inflection Levels
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The 3 Best Fintech Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Excel Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.